Healio: Immunotherapy does not increase surgery complications for oral cavity cancer patients
Treating patients with advanced oral cavity cancer with an immunotherapy drug prior to surgery did not increase the risk for serious complications and was shown to potentially reduce poor surgical outcomes, according to new research presented at the American Head & Neck Society Annual Meeting led by University of Cincinnati researchers.
Researchers led by Alice L. Tang, MD, assistant clinical professor in the UC College of Medicine, reviewed the data of 32 patients enrolled in a clinical trial who received the immunotherapy drug pembrolizumab prior to surgery.
Complications are common after surgery to remove primary oral cavity cancer. However, the results showed no relevant differences in surgical outcomes between the control group and those who received the immunotherapy other than a statistically significant decrease in instances of lockjaw among those who received the immunotherapy.
“A lot of us have been suspicious that perhaps immunotherapy could cause poor wound healing, and this contradicts other data that have already been published,” Tang told Healio. “Surgeons in the community and clinicians should be reassured that there is emerging data that tells us more about adverse events after neoadjuvant immunotherapy, and that perhaps we’ll be OK with wound healing in this scenario.”
Tang said further study is needed with a larger sample size of patients to confirm findings.
“Neoadjuvant immunotherapy is going to be more and more important for head and neck cancers, particularly advanced disease,” Tang said. “We really need to know much more about the surgical implications and how this can affect outcomes.”
Featured photo at top of surgical tools in an operating room. Photo/University of Cincinnati.
Related Stories
Scientists discover how snakes stand upright without limbs
April 3, 2026
Smithsonian magazine highlights a study co-authored by UC Professor Bruce Jayne, an expert in snake locomotion, about how snakes stand upright without arms or legs.
On track: Hoffman Honors Scholar studies public transit
April 2, 2026
Public transit is where Zane Sawyer’s lifelong passion for travel meets his commitment to making an impact. The University of Cincinnati first-year geography major in the College of Arts & Sciences and member of the second cohort of Hoffman Honors Scholars (HHS) has hit the ground running, designing a research project intended to capture both how public transit works and how its users perceive it.
UC design student works with sports greats in co-op
April 2, 2026
Spectrum News profiles UC College of Design, Architecture, Art, and Planning communication design student Jayden Balwally, who had an internship with the Oklahoma City Thunder and worked with the Heisman Trophy Trust and the College Football Playoff.